Cardio Diagnostics Holdings Inc. Common stock Share Price
CDIOCardio Diagnostics Holdings Inc. Common stock Stock Performance
Open $1.88 | Prev. Close $1.82 | Circuit Range N/A |
Day Range $1.88 - $1.93 | Year Range $0.97 - $7.89 | Volume 1,153 |
Average Traded $1.91 |
Cardio Diagnostics Holdings Inc. Common stock Share Price Chart
About Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, including concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Cardio Diagnostics Holdings Inc. Common stock Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
07-May-26 | $1.77 | $1.82 | -1.62% |
06-May-26 | $1.88 | $1.85 | +1.65% |
05-May-26 | $1.90 | $1.82 | -11.22% |
04-May-26 | $1.97 | $2.05 | +10.81% |
01-May-26 | $1.78 | $1.85 | +3.35% |
30-Apr-26 | $1.78 | $1.79 | +5.92% |
29-Apr-26 | $1.68 | $1.69 | -2.31% |